OP0027 Abnormal B Cell Activation through Cellular Metabolic Reprogramming and Its Relevance To The Pathogenesis of SLE

免疫球蛋白D B细胞 TLR9型 免疫学 生发中心 细胞分化 BCL6公司 生物 分子生物学 医学 抗体 DNA甲基化 基因表达 生物化学 基因
作者
Masataka Torigoe,S. Iwata,K. Sakata,Shingo Nakayamada,Yoshiki Tanaka
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:75 (Suppl 2): 63.1-63
标识
DOI:10.1136/annrheumdis-2016-eular.2223
摘要

Background

B cells play a pivotal role in autoimmune diseases. In SLE, IFN signature is displayed and aberrant function of Toll-like receptors (TLR) for recognizing nucleic acids contributes to its pathology. Peripheral plasmablasts increase in active SLE, but the relevance of cellular metabolisms to B cell differentiation to plasmablasts remains unclear.

Objectives

To examine the mechanism by which cellular metabolic reprogramming regulates human B cell differentiation in vitro, and its involvement in pathological processes of SLE.

Methods

Human B cells were obtained from peripheral blood of healthy donors (HDs), and separated into 3 subsets; naïve (IgD+CD27–), IgM memory (IgD+CD27+) and class-switched (CS) memory B cells (IgD–CD27+). Each subset was cultured with CpG DNA (ligand of TLR9) and/or IFN-α. Plasmablast (CD27hi) differentiation, immunoglobulin (IgM, IgG), and cytokine production (IL-6, IL-10), and cellular metabolism (mTORC1, AMPK, glycolysis) were assessed.

Results

When IgM memory B cells and CS memory B cells were stimulated with CpG, robust production of IL-6 and IL-10 as well as differentiation to plasmablasts were induced. The gene expression of IRF4, XBP1 and PRDM1 was increased by CpG, whereas that of BACH2 and BCL6 was decreased. These responses were amplified by IFN-α, which was abrogated by anti-IFNAR2 Abs. A JAK inhibitor tofacitinib did not attenuate CpG-induced B cell differentiation to plasmablasts, indicating that JAK-mediated signaling by autocrine IL-6 and IL-10 was not relevant to the differentiation. Next, we analyzed cellular metabolic reprogramming during B cell differentiation, which was recently highlighted for its involvement in T cell differentiation. CpG stimulation strongly induced p-mTORC1 and lactic acid production, indicating that there is a metabolic shift to glycolysis in B cells. IFN-α further augmented this pathway. However, a glycolysis inhibitor, 2-deoxy-D-glucose and an mTORC1 inhibitor, rapamycin significantly abrogated lactic acid production, cytokine production and plasmablast differentiation of B cells in a dose-dependent manner. AMPK activators, metformin and AICAR, which are known to indirectly inhibit mTORC1, not only suppressed plasmablast differentiation but also induced IgD–CD27– memory B cells. These results indicate that CpG and IFN-α shifted mTORC1/AMPK balance toward mTORC1 activation and glycolysis, leading to plasmablast differentiation. Interestingly, p-mTORC1 was significantly enhanced in B cells of SLE patients, compared to HDs (p<0.05), and it positively correlated with percentage of peripheral plasmablasts (r =0.709, p<0.01) and SLEDAI score (r =0.453, p<0.05), and negatively correlated with CH50 (r = -0.452, p<0.05).

Conclusions

CpG and IFN-α shifted mTORC1/AMPK balance toward mTORC1 activation and glycolysis, resulting in plasmablast differentiation, especially in memory B cells. The metabolic shift to anabolism supplied sufficient proteins and nucleic acids for rapid cell proliferation, permitting efficient differentiation to plasmablasts. Abnormal B cell activation through cellular metabolic reprogramming could contribute to SLE pathology. Thus, we first propose the disturbance of “immunometabolism” in B cells, and the regulation of B cell metabolism can provide a new therapeutic strategy against SLE.

Disclosure of Interest

M. Torigoe: None declared, S. Iwata: None declared, K. Sakata Employee of: Mitsubishi Tanabe Pharma, S. Nakayamada: None declared, Y. Tanaka Grant/research support from: Mitsubishi-Tanabe, Takeda, Chugai, Astellas, Eisai, Taisho-Toyama, Kyowa-Kirin, Abbvie, Bristol-Myers, Consultant for: Abbvie, Daiichi-Sankyo, Chugai, Takeda, Mitsubishi-Tanabe, Bristol-Myers, Astellas, Eisai, Janssen, Pfizer, Asahi-kasei, Eli Lilly, GlaxoSmithKline, UCB, Teijin, MSD, Santen, Speakers bureau: Abbvie, Daiichi-Sankyo, Chugai, Takeda, Mitsubishi-Tanabe, Bristol-Myers, Astellas, Eisai, Janssen, Pfizer, Asahi-kasei, Eli Lilly, GlaxoSmithKline, UCB, Teijin, MSD, Santen

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
只争朝夕的应助被科研通管家采纳,获得10
刚刚
刚刚
大个的应助被科研通管家采纳,获得10
刚刚
刚刚
无极微光的应助被科研通管家采纳,获得20
刚刚
njw完成签到,获得积分10
刚刚
传奇3的应助被科研通管家采纳,获得10
1秒前
汉堡包的应助被科研通管家采纳,获得10
1秒前
老刀完成签到,获得积分10
2秒前
2秒前
转山转水转出了自我完成签到,获得积分10
2秒前
每天都不想读文献完成签到,获得积分10
3秒前
66发布了新的文献求助10
5秒前
6秒前
6秒前
7Hz完成签到 ,获得积分10
6秒前
CCY完成签到,获得积分10
7秒前
安尔完成签到 ,获得积分10
7秒前
8秒前
在水一方的应助被无奈柚子采纳,获得10
8秒前
giA关注了科研通微信公众号
8秒前
xiao发布了新的文献求助10
10秒前
积极的裘发布了新的文献求助10
10秒前
jing完成签到 ,获得积分10
10秒前
陈凌雪发布了新的文献求助10
11秒前
11秒前
liyongfei完成签到,获得积分10
11秒前
7Hz关注了科研通微信公众号
12秒前
12秒前
李程辉完成签到 ,获得积分10
12秒前
irisyan完成签到 ,获得积分10
13秒前
King完成签到 ,获得积分10
13秒前
17秒前
xiahaijun发布了新的文献求助10
18秒前
18秒前
orixero的应助被66采纳,获得10
18秒前
18秒前
linaoctcn完成签到,获得积分10
19秒前
无聊的剑心完成签到,获得积分10
19秒前
jinxli完成签到 ,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054